Cargando…

Regulatory T cells in COVID-19

The outbreak of coronavirus disease 2019 (COVID-19) is caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which leads to the disruption of immune system, exacerbated inflammation, and even multiple organ dysfunction syndrome. Regulatory T cells (Tregs) are an im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huan, Wang, Zhao, Cao, Wen, Wu, Qianqian, Yuan, Yujia, Zhang, Xiangjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460308/ https://www.ncbi.nlm.nih.gov/pubmed/34631206 http://dx.doi.org/10.14336/AD.2021.0709

Ejemplares similares

Ischemic Stroke: An Underestimated Complication of COVID-19
por: Cao, Wen, et al.
Publicado: (2021)

Regulatory T cells in ischemic stroke
por: Wang, Huan, et al.
Publicado: (2021)

Legal and regulatory processes for Japan’s COVID-19 immunization program
por: Yamamoto, Norihisa, et al.
Publicado: (2021)

Current regulatory approaches for accessing potential COVID-19 therapies
por: Halimi, Vesa, et al.
Publicado: (2020)

COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use
por: Beninger, Paul
Publicado: (2020)

The Role of Regulatory Sciences from the Perspective of the Cuban Medicines Regulatory Agency: The Impact of COVID-19 in Promoting Innovation, Cooperation and Scientific Thinking
por: Romeu, Belkis, et al.
Publicado: (2021)

A commentary on “Economic evaluation of programs against COVID-19: A systematic review”
por: Ding, Qianqian, et al.
Publicado: (2021)

Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19
por: Li, Chenghai, et al.
Publicado: (2020)

Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Differentiation of T Regulatory Cells by Immature Dendritic Cells
por: Roncarolo, Maria-Grazia, et al.
Publicado: (2001)

A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
por: Zhang, Jie, et al.
Publicado: (2020)

Revisiting regulatory T cells for stroke therapy
por: Lee, Juneyoung, et al.
Publicado: (2022)

Advances and Challenges of Epidemic Outbreaks in the Post-COVID-19 Era in China
por: Zhang, Chao, et al.
Publicado: (2023)

Advancing regulatory science, advancing regulatory practice
por: Kurz, Xavier
Publicado: (2017)

Regulatory T cells and IL-10 in allergic inflammation
por: Hawrylowicz, Catherine M.
Publicado: (2005)

The kinetics of T regulatory cells in shock: beyond sepsis
por: Christaki, Eirini, et al.
Publicado: (2010)

Dry antibiotic pipeline: Regulatory bottlenecks and regulatory reforms
por: Gupta, Sandeep Kumar, et al.
Publicado: (2014)

Can Circulating Regulatory T Cells Predict Cardiovascular Disease?
por: Björkbacka, Harry
Publicado: (2016)

Type I regulatory T cells in malaria: of mice and men
por: Nideffer, Jason, et al.
Publicado: (2023)

Targeting inflammation to improve regulatory T cell therapy for immunopathologies
por: Salomon, Benoit L.
Publicado: (2022)

Timely mental health services contribute to the containment of COVID-19 pandemic in China
por: Zhang, Ning, et al.
Publicado: (2020)

Chimeric Antigen Receptor Regulatory T Cell in Transplantation: The Future of Cell Therapy?
por: Lamarche, Caroline, et al.
Publicado: (2022)

Neurological Manifestations of COVID-19: Causality or Coincidence?
por: Zhao, Fangfang, et al.
Publicado: (2021)

Dysfunctional Coagulation in COVID-19: From Cell to Bedside
por: Wang, Jie, et al.
Publicado: (2020)

Role of regulatory T cells in experimental arthritis and implications for clinical use
por: Londei, Marco
Publicado: (2005)

Tipping the Balance in Metabolic Regulation: Regulating Regulatory T Cells by Costimulation
por: Qi, Ling
Publicado: (2014)

The occurrence of diarrhea in COVID-19 patients
por: Li, Xiang-Yu, et al.
Publicado: (2020)

Backward, upside down and inside out — the regulatory evolution of vertebrates
por: Wu, Chung-I, et al.
Publicado: (2019)

Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?
por: Yeung, Man Lung, et al.
Publicado: (2007)

Progress in mental health research and service provision in China: Lessons learnt from COVID-19 and SARS epidemics
por: Li, Wen, et al.
Publicado: (2021)

Construction of a Human Cell Landscape of COVID-19 Infection at Single-cell Level
por: He, Jian, et al.
Publicado: (2021)

Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy
por: Wu, Junping, et al.
Publicado: (2020)

Legitimizing Values in Regulatory Science
por: Fernández Pinto, Manuela, et al.
Publicado: (2019)

Mesenchymal stem cells in the treatment of severe COVID-19
por: Kesari, Santosh, et al.
Publicado: (2021)

A Stepwise Approach to Inbound Passenger Management at a COVID-19 Temporary Medical Observation Site
por: Zhang, Yongfang, et al.
Publicado: (2021)

Rhinovirus remains prevalent in school teenagers during fight against COVID‐19 pandemic
por: Wu, Di, et al.
Publicado: (2020)

Clinical experiences in the management of critically ill patients with COVID-19 in a designated children’s hospital in China
por: Liu, Gong-Bao, et al.
Publicado: (2023)

The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2018)

The role played by traditional Chinese medicine in preventing and treating COVID-19 in China
por: Li, Qingwei, et al.
Publicado: (2020)

New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19: In Responding to a Global Health Crisis, Industry is Discovering New, Efficient Ways of Meeting Objectives
por: Wegner, Max
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jsocqps2de30fb6muqofv30im